Cargando…

Evaluation and refinement of the PRESTARt tool for identifying 12–14 year olds at high lifetime risk of developing type 2 diabetes compared to a clinicians assessment of risk: a cross-sectional study

BACKGROUND: Traditionally Type 2 Diabetes Mellitus (T2DM) was associated with older age, but is now being increasingly diagnosed in younger populations due to the increasing prevalence of obesity and inactivity. We aimed to evaluate whether a tool developed for community use to identify adolescents...

Descripción completa

Detalles Bibliográficos
Autores principales: Gray, Laura J., Brady, Emer M., Albaina, Olatz, Edwardson, Charlotte L., Harrington, Deirdre, Khunti, Kamlesh, Miksza, Joanne, Raposo, João Filipe, Smith, Ellesha, Vazeou, Andriani, Vergara, Itziar, Weihrauch-Blüher, Susann, Davies, Melanie J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6659313/
https://www.ncbi.nlm.nih.gov/pubmed/31345191
http://dx.doi.org/10.1186/s12902-019-0410-3
_version_ 1783439112148090880
author Gray, Laura J.
Brady, Emer M.
Albaina, Olatz
Edwardson, Charlotte L.
Harrington, Deirdre
Khunti, Kamlesh
Miksza, Joanne
Raposo, João Filipe
Smith, Ellesha
Vazeou, Andriani
Vergara, Itziar
Weihrauch-Blüher, Susann
Davies, Melanie J.
author_facet Gray, Laura J.
Brady, Emer M.
Albaina, Olatz
Edwardson, Charlotte L.
Harrington, Deirdre
Khunti, Kamlesh
Miksza, Joanne
Raposo, João Filipe
Smith, Ellesha
Vazeou, Andriani
Vergara, Itziar
Weihrauch-Blüher, Susann
Davies, Melanie J.
author_sort Gray, Laura J.
collection PubMed
description BACKGROUND: Traditionally Type 2 Diabetes Mellitus (T2DM) was associated with older age, but is now being increasingly diagnosed in younger populations due to the increasing prevalence of obesity and inactivity. We aimed to evaluate whether a tool developed for community use to identify adolescents at high lifetime risk of developing T2DM agreed with a risk assessment conducted by a clinician using data collected from five European countries. We also assessed whether the tool could be simplified. METHODS: To evaluate the tool we collected data from 636 adolescents aged 12–14 years from five European countries. Each participant’s data were then assessed by two clinicians independently, who judged each participant to be at either low or high risk of developing T2DM in their lifetime. This was used as the gold standard to which the tool was evaluated and refined. RESULTS: The refined tool categorised adolescents at high risk if they were overweight/obese and had at least one other risk factor (High waist circumference, family history of diabetes, parental obesity, not breast fed, high sugar intake, high screen time, low physical activity and low fruit and vegetable intake). Of those found to be at high risk by the clinicians, 93% were also deemed high risk by the tool. The specificity shows that 67% of those deemed at low risk by the clinicians were also found to be a low risk by the tool. CONCLUSIONS: We have evaluated a tool for identifying adolescents with risk factors associated with the development of T2DM in the future. Future work to externally validate the tool using prospective data including T2DM incidence is required. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12902-019-0410-3) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6659313
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-66593132019-08-01 Evaluation and refinement of the PRESTARt tool for identifying 12–14 year olds at high lifetime risk of developing type 2 diabetes compared to a clinicians assessment of risk: a cross-sectional study Gray, Laura J. Brady, Emer M. Albaina, Olatz Edwardson, Charlotte L. Harrington, Deirdre Khunti, Kamlesh Miksza, Joanne Raposo, João Filipe Smith, Ellesha Vazeou, Andriani Vergara, Itziar Weihrauch-Blüher, Susann Davies, Melanie J. BMC Endocr Disord Research Article BACKGROUND: Traditionally Type 2 Diabetes Mellitus (T2DM) was associated with older age, but is now being increasingly diagnosed in younger populations due to the increasing prevalence of obesity and inactivity. We aimed to evaluate whether a tool developed for community use to identify adolescents at high lifetime risk of developing T2DM agreed with a risk assessment conducted by a clinician using data collected from five European countries. We also assessed whether the tool could be simplified. METHODS: To evaluate the tool we collected data from 636 adolescents aged 12–14 years from five European countries. Each participant’s data were then assessed by two clinicians independently, who judged each participant to be at either low or high risk of developing T2DM in their lifetime. This was used as the gold standard to which the tool was evaluated and refined. RESULTS: The refined tool categorised adolescents at high risk if they were overweight/obese and had at least one other risk factor (High waist circumference, family history of diabetes, parental obesity, not breast fed, high sugar intake, high screen time, low physical activity and low fruit and vegetable intake). Of those found to be at high risk by the clinicians, 93% were also deemed high risk by the tool. The specificity shows that 67% of those deemed at low risk by the clinicians were also found to be a low risk by the tool. CONCLUSIONS: We have evaluated a tool for identifying adolescents with risk factors associated with the development of T2DM in the future. Future work to externally validate the tool using prospective data including T2DM incidence is required. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12902-019-0410-3) contains supplementary material, which is available to authorized users. BioMed Central 2019-07-25 /pmc/articles/PMC6659313/ /pubmed/31345191 http://dx.doi.org/10.1186/s12902-019-0410-3 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Gray, Laura J.
Brady, Emer M.
Albaina, Olatz
Edwardson, Charlotte L.
Harrington, Deirdre
Khunti, Kamlesh
Miksza, Joanne
Raposo, João Filipe
Smith, Ellesha
Vazeou, Andriani
Vergara, Itziar
Weihrauch-Blüher, Susann
Davies, Melanie J.
Evaluation and refinement of the PRESTARt tool for identifying 12–14 year olds at high lifetime risk of developing type 2 diabetes compared to a clinicians assessment of risk: a cross-sectional study
title Evaluation and refinement of the PRESTARt tool for identifying 12–14 year olds at high lifetime risk of developing type 2 diabetes compared to a clinicians assessment of risk: a cross-sectional study
title_full Evaluation and refinement of the PRESTARt tool for identifying 12–14 year olds at high lifetime risk of developing type 2 diabetes compared to a clinicians assessment of risk: a cross-sectional study
title_fullStr Evaluation and refinement of the PRESTARt tool for identifying 12–14 year olds at high lifetime risk of developing type 2 diabetes compared to a clinicians assessment of risk: a cross-sectional study
title_full_unstemmed Evaluation and refinement of the PRESTARt tool for identifying 12–14 year olds at high lifetime risk of developing type 2 diabetes compared to a clinicians assessment of risk: a cross-sectional study
title_short Evaluation and refinement of the PRESTARt tool for identifying 12–14 year olds at high lifetime risk of developing type 2 diabetes compared to a clinicians assessment of risk: a cross-sectional study
title_sort evaluation and refinement of the prestart tool for identifying 12–14 year olds at high lifetime risk of developing type 2 diabetes compared to a clinicians assessment of risk: a cross-sectional study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6659313/
https://www.ncbi.nlm.nih.gov/pubmed/31345191
http://dx.doi.org/10.1186/s12902-019-0410-3
work_keys_str_mv AT graylauraj evaluationandrefinementoftheprestarttoolforidentifying1214yearoldsathighlifetimeriskofdevelopingtype2diabetescomparedtoacliniciansassessmentofriskacrosssectionalstudy
AT bradyemerm evaluationandrefinementoftheprestarttoolforidentifying1214yearoldsathighlifetimeriskofdevelopingtype2diabetescomparedtoacliniciansassessmentofriskacrosssectionalstudy
AT albainaolatz evaluationandrefinementoftheprestarttoolforidentifying1214yearoldsathighlifetimeriskofdevelopingtype2diabetescomparedtoacliniciansassessmentofriskacrosssectionalstudy
AT edwardsoncharlottel evaluationandrefinementoftheprestarttoolforidentifying1214yearoldsathighlifetimeriskofdevelopingtype2diabetescomparedtoacliniciansassessmentofriskacrosssectionalstudy
AT harringtondeirdre evaluationandrefinementoftheprestarttoolforidentifying1214yearoldsathighlifetimeriskofdevelopingtype2diabetescomparedtoacliniciansassessmentofriskacrosssectionalstudy
AT khuntikamlesh evaluationandrefinementoftheprestarttoolforidentifying1214yearoldsathighlifetimeriskofdevelopingtype2diabetescomparedtoacliniciansassessmentofriskacrosssectionalstudy
AT mikszajoanne evaluationandrefinementoftheprestarttoolforidentifying1214yearoldsathighlifetimeriskofdevelopingtype2diabetescomparedtoacliniciansassessmentofriskacrosssectionalstudy
AT raposojoaofilipe evaluationandrefinementoftheprestarttoolforidentifying1214yearoldsathighlifetimeriskofdevelopingtype2diabetescomparedtoacliniciansassessmentofriskacrosssectionalstudy
AT smithellesha evaluationandrefinementoftheprestarttoolforidentifying1214yearoldsathighlifetimeriskofdevelopingtype2diabetescomparedtoacliniciansassessmentofriskacrosssectionalstudy
AT vazeouandriani evaluationandrefinementoftheprestarttoolforidentifying1214yearoldsathighlifetimeriskofdevelopingtype2diabetescomparedtoacliniciansassessmentofriskacrosssectionalstudy
AT vergaraitziar evaluationandrefinementoftheprestarttoolforidentifying1214yearoldsathighlifetimeriskofdevelopingtype2diabetescomparedtoacliniciansassessmentofriskacrosssectionalstudy
AT weihrauchbluhersusann evaluationandrefinementoftheprestarttoolforidentifying1214yearoldsathighlifetimeriskofdevelopingtype2diabetescomparedtoacliniciansassessmentofriskacrosssectionalstudy
AT daviesmelaniej evaluationandrefinementoftheprestarttoolforidentifying1214yearoldsathighlifetimeriskofdevelopingtype2diabetescomparedtoacliniciansassessmentofriskacrosssectionalstudy
AT evaluationandrefinementoftheprestarttoolforidentifying1214yearoldsathighlifetimeriskofdevelopingtype2diabetescomparedtoacliniciansassessmentofriskacrosssectionalstudy